These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23760064)

  • 1. Schistosomiasis and impaired response to antiretroviral therapy among HIV-infected patients in Tanzania.
    Efraim L; Peck RN; Kalluvya SE; Kabangila R; Mazigo HD; Mpondo B; Bang H; Todd J; Fitzgerald DW; Downs JA
    J Acquir Immune Defic Syndr; 2013 Apr; 62(5):e153-6. PubMed ID: 23760064
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between CD4+ T-lymphocyte counts and fecal excretion of Schistosoma mansoni eggs in patients coinfected with S. mansoni and human immunodeficiency virus before and after initiation of antiretroviral therapy.
    Muok EM; Simiyu EW; Ochola EA; Ng'ang'a ZW; Secor WE; Karanja DM; Mwinzi PN
    Am J Trop Med Hyg; 2013 Jul; 89(1):42-5. PubMed ID: 23669231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and intensity of
    Mazigo HD; Kirway L; Ambrose EA
    BMJ Open; 2019 Jul; 9(7):e029749. PubMed ID: 31345980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Viral Loads Are Not Elevated in Individuals Co-infected With
    Colombe S; Corstjens PLAM; de Dood CJ; Miyaye D; Magawa RG; Mngara J; Kalluvya SE; van Lieshout L; van Dam GJ; Downs JA
    Front Immunol; 2018; 9():2005. PubMed ID: 30237799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications of coinfection for excretion of eggs.
    Kallestrup P; Zinyama R; Gomo E; Butterworth AE; van Dam GJ; Erikstrup C; Ullum H
    J Infect Dis; 2005 Apr; 191(8):1311-20. PubMed ID: 15776378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania.
    Stete K; Glass TR; van Dam GJ; Ntamatungiro A; Letang E; de Dood CJ; Corstjens PLAM; Ndege R; Mapesi H; Kern WV; Hatz C; Weisser M; Utzinger J; Müller MC
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006844. PubMed ID: 30332404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosomiasis and HIV-1 viral load in HIV-infected outpatients with immunological failure in Tanzania: a case-control study.
    Masikini P; Colombe S; Marti A; Desderius B; de Dood CJ; Corstjens PLAM; van Dam GJ; Seugendo M; Kalluvya S; Downs JA
    BMC Infect Dis; 2019 Mar; 19(1):249. PubMed ID: 30866830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and outcomes of HIV-infected antiretroviral-naive patients with discordant responses to combination antiretroviral treatment in Asian and Australian populations: results from APHOD.
    Choi JY; Zhou J; Giles M; Broom J; Templeton DJ; Law MG; Chaiwarith R; Tanuma J;
    J Acquir Immune Defic Syndr; 2011 May; 57(1):e13-5. PubMed ID: 21786460
    [No Abstract]   [Full Text] [Related]  

  • 9. Co-infection with Schistosoma mansoni and Human Immunodeficiency Virus-1 (HIV-1) among residents of fishing villages of north-western Tanzania.
    Mazigo HD; Dunne DW; Wilson S; Kinung'hi SM; Pinot de Moira A; Jones FM; Morona D; Nuwaha F
    Parasit Vectors; 2014 Dec; 7():587. PubMed ID: 25511298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of schistosome infection on long-term HIV/AIDS outcomes.
    Colombe S; Machemba R; Mtenga B; Lutonja P; Kalluvya SE; de Dood CJ; Hoekstra PT; van Dam GJ; Corstjens PLAM; Urassa M; Changalucha JM; Todd J; Downs JA
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006613. PubMed ID: 29965987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection.
    Kallestrup P; Zinyama R; Gomo E; Butterworth AE; van Dam GJ; Gerstoft J; Erikstrup C; Ullum H
    Clin Infect Dis; 2006 Jun; 42(12):1781-9. PubMed ID: 16705587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.
    Gunda DW; Kilonzo SB; Kamugisha E; Rauya EZ; Mpondo BC
    BMC Res Notes; 2017 Jun; 10(1):197. PubMed ID: 28595630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic and virologic responses to antiretroviral therapy in treatment-naïve, HIV-infected elderly patients.
    Ocheretyaner ER; Yusuff J; Park TE
    Int J STD AIDS; 2019 Nov; 30(13):1304-1310. PubMed ID: 31726933
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania.
    Semvua SK; Orrell C; Mmbaga BT; Semvua HH; Bartlett JA; Boulle AA
    PLoS One; 2017; 12(12):e0189460. PubMed ID: 29252984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of opportunistic intestinal parasitic infections among HIV-infected patients with low CD4 cells counts in France in the combination antiretroviral therapy era.
    Pavie J; Menotti J; Porcher R; Donay JL; Gallien S; Sarfati C; Derouin F; Molina JM
    Int J Infect Dis; 2012 Sep; 16(9):e677-9. PubMed ID: 22771183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral treatment failure predicts mortality in rural Tanzania.
    Pettersen PS; Brox IK; Naman E; Bruun JN; Dyrhol-Riise AM; Trøseid M; Johannessen A
    Int J STD AIDS; 2015 Aug; 26(9):633-9. PubMed ID: 25122578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania.
    Kalinjuma AV; Glass TR; Weisser M; Myeya SJ; Kasuga B; Kisung'a Y; Sikalengo G; Katende A; Battegay M; Vanobberghen F;
    J Int AIDS Soc; 2020 Mar; 23(3):e25460. PubMed ID: 32128998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania.
    Johnson OO; Benjamin DK; Benjamin DK; Schimana W; Tillekeratne LG; Crump JA; Landman KZ; Kinabo GD; Mmbaga B; Msuya LJ; Shao JF; Swai ME; Cunningham CK
    Pediatr Infect Dis J; 2009 Jun; 28(6):493-7. PubMed ID: 19436238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania.
    Mosha F; Muchunguzi V; Matee M; Sangeda RZ; Vercauteren J; Nsubuga P; Lyamuya E; Vandamme AM
    BMC Public Health; 2013 Jan; 13():38. PubMed ID: 23320567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of change in CD4 lymphocyte count and weight among HIV infected patients on anti-retroviral treatment in Ethiopia: a retrospective longitudinal study.
    Reda AA; Biadgilign S; Deribew A; Gebre B; Deribe K
    PLoS One; 2013; 8(4):e58595. PubMed ID: 23573191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.